These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16923174)

  • 1. In vivo detection of Egr2 binding to target genes during peripheral nerve myelination.
    Jang SW; LeBlanc SE; Roopra A; Wrabetz L; Svaren J
    J Neurochem; 2006 Sep; 98(5):1678-87. PubMed ID: 16923174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locus-wide identification of Egr2/Krox20 regulatory targets in myelin genes.
    Jang SW; Srinivasan R; Jones EA; Sun G; Keles S; Krueger C; Chang LW; Nagarajan R; Svaren J
    J Neurochem; 2010 Dec; 115(6):1409-20. PubMed ID: 21044070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct regulation of myelin protein zero expression by the Egr2 transactivator.
    LeBlanc SE; Jang SW; Ward RM; Wrabetz L; Svaren J
    J Biol Chem; 2006 Mar; 281(9):5453-60. PubMed ID: 16373334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the PMP22 gene through an intronic enhancer.
    Jones EA; Lopez-Anido C; Srinivasan R; Krueger C; Chang LW; Nagarajan R; Svaren J
    J Neurosci; 2011 Mar; 31(11):4242-50. PubMed ID: 21411665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide analysis of EGR2/SOX10 binding in myelinating peripheral nerve.
    Srinivasan R; Sun G; Keles S; Jones EA; Jang SW; Krueger C; Moran JJ; Svaren J
    Nucleic Acids Res; 2012 Aug; 40(14):6449-60. PubMed ID: 22492709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression.
    Nagarajan R; Svaren J; Le N; Araki T; Watson M; Milbrandt J
    Neuron; 2001 May; 30(2):355-68. PubMed ID: 11394999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active gene repression by the Egr2.NAB complex during peripheral nerve myelination.
    Mager GM; Ward RM; Srinivasan R; Jang SW; Wrabetz L; Svaren J
    J Biol Chem; 2008 Jun; 283(26):18187-97. PubMed ID: 18456662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic regulation of Schwann cell enhancers after peripheral nerve injury.
    Hung HA; Sun G; Keles S; Svaren J
    J Biol Chem; 2015 Mar; 290(11):6937-50. PubMed ID: 25614629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathy-associated Egr2 mutants disrupt cooperative activation of myelin protein zero by Egr2 and Sox10.
    LeBlanc SE; Ward RM; Svaren J
    Mol Cell Biol; 2007 May; 27(9):3521-9. PubMed ID: 17325040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of myelin protein zero by early growth response 2 through upstream and intragenic elements.
    Jang SW; Svaren J
    J Biol Chem; 2009 Jul; 284(30):20111-20. PubMed ID: 19487693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of cholesterol/lipid biosynthetic genes by Egr2/Krox20 during peripheral nerve myelination.
    Leblanc SE; Srinivasan R; Ferri C; Mager GM; Gillian-Daniel AL; Wrabetz L; Svaren J
    J Neurochem; 2005 May; 93(3):737-48. PubMed ID: 15836632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tead1 regulates the expression of Peripheral Myelin Protein 22 during Schwann cell development.
    Lopez-Anido C; Poitelon Y; Gopinath C; Moran JJ; Ma KH; Law WD; Antonellis A; Feltri ML; Svaren J
    Hum Mol Genet; 2016 Jul; 25(14):3055-3069. PubMed ID: 27288457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid regulates myelin formation in the peripheral nervous system.
    Latasa MJ; Ituero M; Moran-Gonzalez A; Aranda A; Cosgaya JM
    Glia; 2010 Sep; 58(12):1451-64. PubMed ID: 20648638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of peripheral nerve expression profiles identifies a novel myelin glycoprotein, MP11.
    Ryu EJ; Yang M; Gustin JA; Chang LW; Freimuth RR; Nagarajan R; Milbrandt J
    J Neurosci; 2008 Jul; 28(30):7563-73. PubMed ID: 18650334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COUP-TFII plays a role in cAMP-induced Schwann cell differentiation and in vitro myelination by up-regulating Krox20.
    Han SH; Kim YH; Park SJ; Cho JG; Shin YK; Hong YB; Yun J; Han JY; Park HT; Park JI
    J Neurochem; 2023 Jun; 165(5):660-681. PubMed ID: 36648143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of NAB corepressor genes in Schwann cells.
    Srinivasan R; Jang SW; Ward RM; Sachdev S; Ezashi T; Svaren J
    BMC Mol Biol; 2007 Dec; 8():117. PubMed ID: 18096076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs 93-5p, 106b-5p, 17-5p, and 140-5p target the expression of early growth response protein 2 in Schwann cells.
    Sohn EJ; Nam YK; Park HT
    Neuroreport; 2019 Feb; 30(3):241-246. PubMed ID: 30614908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Krox20 gene expression by Sox10 in myelinating Schwann cells.
    Reiprich S; Kriesch J; Schreiner S; Wegner M
    J Neurochem; 2010 Feb; 112(3):744-54. PubMed ID: 19922439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Peripheral Nerve Myelin Maintenance by Gene Repression through Polycomb Repressive Complex 2.
    Ma KH; Hung HA; Srinivasan R; Xie H; Orkin SH; Svaren J
    J Neurosci; 2015 Jun; 35(22):8640-52. PubMed ID: 26041929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTCF-mediated chromatin looping in EGR2 regulation and SUZ12 recruitment critical for peripheral myelination and repair.
    Wang J; Wang J; Yang L; Zhao C; Wu LN; Xu L; Zhang F; Weng Q; Wegner M; Lu QR
    Nat Commun; 2020 Aug; 11(1):4133. PubMed ID: 32807777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.